An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied on insulin to survive, but the treatment does not stop the immune system from continuing its attack on the body’s insulin-producing [...]